Drugs and medical ethics

Area of Science:

• Integrative Oncology
• Medical Ethics
• Pharmaceutical Research

Background:

• Naturopathy is gaining global interest, prompting scrutiny of its methods and outcomes.
• The use of unconventional therapies, including 'oncolytic' drugs, presents legal and ethical challenges.
• Physicians are increasingly encountering patients seeking or using naturopathic treatments.

Purpose of the Study:

• To examine the ethical implications of physicians prescribing unverified 'oncolytic' drugs within naturopathic practices.
• To analyze cases where conventional cancer treatment was discontinued in favor of naturopathic interventions.
• To discuss the potential, albeit limited, role of naturopathy within established medical frameworks.

Main Methods:

• Case report analysis of two 'oncolytic' drugs used in naturopathic settings.
• Review of ethical responsibilities concerning the prescription of fringe medicine.
• Examination of drug approval processes and their absence in the reported cases.

Main Results:

• The 'oncolytic' drugs were not developed by cancer researchers nor did they undergo standard pharmaceutical analysis.
• Conventional treatments were withdrawn during the use of these naturopathic drugs.
• Significant ethical questions arise regarding physician responsibility in prescribing unvalidated therapies.

Conclusions:

• The use of unverified 'oncolytic' drugs in naturopathy raises serious ethical and legal concerns.
• Physicians bear ethical responsibility when recommending fringe medicine that leads to the cessation of evidence-based care.
• Naturopathy's integration into official medicine requires careful consideration of safety, efficacy, and ethical guidelines.